Sort
30,917 grants matching “tumor microenvironment”
Development of TGF-beta antagonists for cancer therapy
$619,633Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Development and validation of an autologous mouse model for the study of immune interactions with glioblastoma
$619,628Zev Ari Binder · University Of Pennsylvania · R37 · FY2024 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$619,610Gerald V Denis · Boston University Medical Campus · R01 · FY2021 · CA
RNAi screen for chromatin modifiers in DNA repair and aging
$619,591Philipp Oberdoerffer · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
$619,505John Kurhanewicz · University Of California, San Francisco · R01 · FY2015 · CA
MOLECULAR DISSECTION OF SEIZURE MICROENVIRONMENT IN MALIGNANT GLIOMA
$619,488Jeffrey Noebels · Baylor College Of Medicine · R01 · FY2022 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$619,470Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Neural Activity Signatures of Tumor Infiltration in the Human Brain
$619,470Angelique C Paulk · Massachusetts General Hospital · R01 · FY2024 · NS
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis
$619,441Han Xiao · Rice University · R01 · FY2024 · CA
Preclinical Testing of Targeted Therapies for Neurofibromas
$619,319David W. Clapp · Indiana University Indianapolis · U01 · FY2009 · NS
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
$619,304Balabhaskar Prabhakarpandian · Cfd Research Corporation · R44 · FY2013 · CA
CPMV-Polymer Devices to Enhance the Outcomes of Intratumoral Immunotherapy
$619,294Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2024 · CA
Uncovering the Molecular Determinants of Metastatic Recurrence and Impaired NK Cell Function
$619,279Srinivas Malladi · Ut Southwestern Medical Center · R01 · FY2024 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$619,255Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$619,253Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer
$619,234Amir Zarrinpar · University Of California, San Diego · U01 · FY2022 · CA
Probabilistic Multiscale Modeling of the Tumor Microenvironment
$619,118Wesley Tansey · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$619,098Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Single cell characterization of the biomaterial immune and stromal response
$618,965Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2020 · EB
MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer
$618,912Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
$618,854Emese Zsiros · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
$618,825Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Targeting cellular senescence to inhibit the development and progression of ovarian endometriomas
$618,771Shannon Michelle Hawkins · Indiana University Indianapolis · R01 · FY2025 · HD
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
$618,713Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2023 · CA
AI enhanced lifetime-based mesoscopic in vivo imaging of tissue molecular heterogeneity
$618,698Xavier Intes · Rensselaer Polytechnic Institute · R01 · FY2024 · CA